ニコチンアミドアデニンジヌクレオチド（NAD）の世界市場：市場規模（種類別・用途別・地域別）、将来予測

ニコチンアミドアデニンジヌクレオチド（NAD）の市場規模と予測

ニコチンアミドアデニンジヌクレオチド（NAD）の市場規模は、2024年に4億9,400万米ドルと評価され、予測期間中（2026～2032年）に14％のCAGRで成長し、2032年までに8億7,340万米ドルに達すると予測されています。

NADは、エネルギーを生成するだけでなく、私たちの体を構成する分子を構築し、修復するために必要な化学反応を触媒するために使用されます。「世界のニコチンアミドアデニンジヌクレオチド（NAD）市場」レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界のニコチンアミドアデニンジヌクレオチド（NAD）市場の定義

ニコチンアミドアデニンジヌクレオチド（NAD+）は重要なピリジンヌクレオチドであり、酸化的リン酸化とATP産生、DNA修復、エピジェネティックに調節された遺伝子発現、細胞内カルシウムシグナル伝達、免疫学的機能などに関与する重要な細胞プロセスのいくつかにとって不可欠な補酵素および基質として機能します。その名の通り、アデニン塩基とニコチンアミド塩基の2つのヌクレオチドから構成されています。これらはリン酸基で結合しています。一般に、NADには酸化型と還元型があり、それぞれNAD+、NADHと略されます。さらに、NADは老化に対する重要な補助薬として使用されることもあります。

現代の生物学的研究で最も有名なNADサプリメントのひとつがNADHで、その機能は細胞の生存サイクルを増加させること（アンチエイジング）であるミトコンドリアホルモンです。さらに、NAD+は解糖とともに、エネルギー分子を分解してATPを生成する異化経路で主に利用されます。すべての生細胞の細胞呼吸プロセスは、補酵素ニコチンアミドアデニンジヌクレオチド（NAD）を利用しています。ニコチンアミドアデニンジヌクレオチド（NAD）は、電子を受容したり供与したりすることで、エネルギー代謝に重要な役割を果たしています。さらに、ニコチンアミドアデニンジヌクレオチド（NAD）ブースターは、細胞を標的とすることによって老化と戦う。このサプリメントは、体内のアンチエイジングを促進します。しかし、ほとんどのNAD+サプリメントには、ニコチンアミドリボシド（NR）またはニコチンアミドモノヌクレオチド（NMN）が含まれています。

世界のニコチンアミドアデニンジヌクレオチド（NAD）市場の概要

NADは、エネルギーを生成するだけでなく、私たちの体を構成する分子を構築し、修復するために必要な化学反応を触媒するために使用され、これがマーケットプレースの需要に影響を与え、積極的に成長を後押ししています。さらに、それは細胞の健康を維持するのに役立ちますなど、多くの利点がNADに関連付けられています。さらに、ニコチンアミドアデニンジヌクレオチド（NAD）ブースターは、細胞を標的とすることによって老化と戦う。さらに、免疫システムを高め、DNAを修復するのに役立ちます。また、体力を増強し、新陳代謝を高めるのにも役立ちます。したがって、上記の利点は、ニコチンアミドアデニンジヌクレオチド（NAD）の需要を作成し、順番に市場の成長を後押しするのに役立ちます、さらに、人口の高齢化と貧しい食生活も業界の需要を拡大するのに役立ちます。

NADを使用することで、適切な時間に睡眠と食事をとることができ、マーケットプレースの成長を後押しします。さらに、世界中で人間の可処分所得が増加し、ライフスタイルが変化しています。その結果、ジャンクミールの消費量が増加しています。したがって、ジャンクミールの消費の増加は、体内のコレステロールのレベルの不均衡を引き起こしています。これが医薬品需要を高め、ニコチンアミドアデニンジヌクレオチド（NAD）マーケットプレースの成長を促進すると考えられます。さらに、NADはトリプトファンやニコチン酸から生成されることもあります。さらに、NAD分解の製品別であるニコチンアミドを基質として利用するNAD生成の「サルベージ経路」も、哺乳類細胞で広範にエネルギッシュであり、ヒトがんのサブセットによって特別に利用されているようです。

従って、NADはほとんどのがん治療に使用される可能性があります。したがって、世界中で心血管疾患の数が増加し、それによってニコチンアミドアデニンジヌクレオチド（NAD）市場の成長を促進し、ニコチンアミドアデニンジヌクレオチド（NAD）の需要を作成します。しかし、いくつかの研究では、NADの過剰摂取は、吐き気発疹、頭痛、めまい、膨満感、かゆみや発汗を含む毛穴や皮膚の問題を含むいくつかの副作用を引き起こすことが観察されています。したがって、これらの副作用はマーケットプレースの成長を妨げる可能性があります。

目次

第1章 世界のニコチンアミドアデニンジヌクレオチド（NAD）市場：イントロダクション

• 市場概要
• 分析範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの分析手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界のニコチンアミドアデニンジヌクレオチド（NAD）市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 世界のニコチンアミドアデニンジヌクレオチド（NAD）市場：種類別

• 概要
• 医薬品グレード
• 食品グレード
• その他

第6章 世界のニコチンアミドアデニンジヌクレオチド（NAD）市場：用途別

• 概要
• 栄養補助食品
• 製薬産業
• その他

第7章 世界のニコチンアミドアデニンジヌクレオチド（NAD）市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 世界のニコチンアミドアデニンジヌクレオチド（NAD）市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な開発戦略

第9章 企業プロファイル

• Bontac Bioengineering
• Hubei Widely Chemical Technology
• Allergan
• Synergy Pharmaceuticals
• Novo Nordisk A/S
• Oramed
• Biocon India
• Diabetology
• Catalent
• EnzymeWorks

第10章 主な動向

• 製品上市/開発
• 企業合併・買収 (M&A)
• 事業拡大
• 提携・協力

第11章 付録

• 関連分析

Nicotinamide Adenine Dinucleotide (NAD) Market Size And Forecast

Nicotinamide Adenine Dinucleotide (NAD) Market size was valued at USD 494 Million in 2024 and is projected to reach USD 873.4 Million by 2032, growing at a CAGR of 14% during the forecast period 2026-2032.

NAD is used to catalyze chemical reactions that are required to both generate energy as well as build and repair the molecules that make up our bodies which affect the market demand and positively increase the growth. The Global Nicotinamide Adenine Dinucleotide (NAD) Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Nicotinamide Adenine Dinucleotide (NAD) Market Definition

Nicotinamide adenine dinucleotide (NAD+) is a vital pyridine nucleotide that serves as an essential cofactor and substrate for some of the crucial cellular processes involved in oxidative phosphorylation and ATP production, DNA repair, epigenetically modulated gene expression, intracellular calcium signaling, and immunological functions. As its name implies, it consists of 2 nucleotides one with an adenine base and the other with a nicotinamide base. They are joined by their phosphate groups. Generally, there are two types of NAD first one is oxidized, and the other is reduced form, which is abbreviated as NAD+ and NADH respectively. In addition, NAD may be used as a vital adjunctive drug against aging.

One of the most famous NAD supplements in modern biological research is NADH, a mitochondrial hormone whose function is to increase the existence cycle of cells (anti-aging). Furthermore, NAD+ is mostly utilized in catabolic pathways, together with glycolysis, that smashes down energy molecules to produce ATP. The cellular breathing processes of all living cells make use of the coenzyme Nicotinamide adenine dinucleotide (NAD). Also, it performs a key function in energy metabolism with the aid of using accepting and donating electrons. Furthermore, Nicotinamide adenine dinucleotide (NAD) boosters fight aging by targeting cells. The supplement promotes anti-aging results in the body. However, most NAD+ supplements include nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN).

Global Nicotinamide Adenine Dinucleotide (NAD) Market Overview

NAD is used to catalyze chemical reactions which are required to both generate energy as well as build and repair the molecules that make up our bodies which have an effect on the marketplace demand and positively boom the growth. In addition, there are numerous advantages are associated with NAD such as it helps in maintaining cell health. In addition, Nicotinamide adenine dinucleotide (NAD) boosters fight aging by targeting cells. Furthermore, it helps in boosting the immune system and repairing DNA. Also, it helps in increasing strength and boosting the metabolism. Thus, the above-mentioned benefits will create a demand for Nicotinamide Adenine Dinucleotide (NAD), which in turn help in boosting the marketplace growth, Furthermore, an aging populace and a poor diet will also assist in growing the demand for the industry.

The use of NAD helps you sleep and eat at the right time which drives the marketplace growth. Moreover, the increase in disposable income of human beings throughout the globe has led to changes in lifestyle. This, in turn, has boosted the consumption of junk meals. Therefore, an increase in the consumption of junk meals has caused an imbalance of levels of cholesterol in the body. This is likely to enhance the demand for medicines, thereby driving the Nicotinamide Adenine Dinucleotide (NAD) marketplace growth. Moreover, NAD may be generated from tryptophan or nicotinic acid. In addition, the "salvage pathway" of NAD production, which makes use of nicotinamide, a by-product of NAD degradation, as a substrate, is also extensively energetic in mammalian cells and looks to be extraordinarily exploited by a subset of human cancers.

Thus, NAD may be used for most cancers treatment. Therefore, a growing number of cardiovascular diseases across the world will create a demand for the Nicotinamide Adenine Dinucleotide (NAD), thereby driving the Nicotinamide Adenine Dinucleotide (NAD) marketplace growth. However, in some studies, it has been observed that excessive consumption of NAD causes some side effects which include nausea rashes, headache, dizziness, bloating, and pores and skin problems which include itching and sweating. Thus, these side effects factors may hamper the marketplace growth.

Global Nicotinamide Adenine Dinucleotide (NAD) Market Segmentation Analysis

The Global Nicotinamide Adenine Dinucleotide (NAD) Market Is Segmented On The Basis Of Type, Application And Geography.

Nicotinamide Adenine Dinucleotide (NAD) Market, By Type

• Pharmaceutical Grade
• Food Grade
• Others

Nicotinamide Adenine Dinucleotide (NAD) Market, By TypeBased on Type, The market is bifurcated into Pharmaceutical Grade, Food Grade, and Others. The Pharmaceutical Grade segment is presumed to become the fastest-growing segment over the forecast period. Supplements that are made in a way to ensure an extremely excessive standard of purity and maximum absorption are certified pharmaceutical grade. In addition, pharmaceutical-grade merchandise must exceed 99% purity and not include any fillers, binders, dyes, or different inactive elements that serve as a vehicle for active substances.

• Furthermore, there are numerous benefits are associated with a pharmaceutical-grade along with BioAvailability and Purity. For instance, increased bioavailability is a major advantage of pharmaceutical-grade supplements, which can be often made with patented technology. In addition, as mentioned, pharmaceutical-grade supplements are required to undergo thorough testing to be at least 99% pure. Thus, the above-mentioned benefits are the key factor that helps in boosting the segment growth.

Nicotinamide Adenine Dinucleotide (NAD) Market, By Application

• Dietary Supplement
• Pharmaceutical Industry
• Others

Based on Application, The market is bifurcated into Dietary Supplement, Pharmaceutical Industry, and Others. Dietary supplements are anticipated to have the largest marketplace share during the forecast period. Nicotinamide adenine dinucleotide (NAD+) is an alternative form of the B3 vitamin and is acquired through the synthesis in the body or as a dietary source and supplement. It is required for over 500 enzymatic reactions and performs key roles in the regulation of almost all important biological processes. Above all, it may permit us to lead healthier and longer lives. In addition, it increases HDL levels and is used in the treatment of pellagra. Thus, demand for vitamin dietary supplements is increasing, owing to the rise in fitness awareness amongst consumers. This is driving the worldwide Nicotinamide Adenine Dinucleotide (NAD) marketplace.

Nicotinamide Adenine Dinucleotide (NAD) Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, The Global Nicotinamide Adenine Dinucleotide (NAD) Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is taking up the largest share in the Nicotinamide Adenine Dinucleotide (NAD) Market and it is estimated that the region will continue dominating the market until the next couple of years. Growing awareness related to the health benefits among the consumer is the key factor that helps in boosting the market growth in the region. In addition, a growing number of cardiovascular diseases in the region will create a demand for the Nicotinamide Adenine Dinucleotide (NAD), thereby driving the Nicotinamide Adenine Dinucleotide (NAD) marketplace growth.

Key Players

The "Global Nicotinamide Adenine Dinucleotide (NAD) Market," study report will provide a valuable insight with an emphasis on the global market, including some of the major players such as Bontac Bioengineering, Hubei Widely Chemical Technology, Allergan, Synergy Pharmaceuticals, Novo Nordisk A/S, Oramed, Biocon India, Diabetology, Catalent, and EnzymeWorks.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In December 2021, Novo Nordisk announces the completion of the Dicerna Pharmaceuticals acquisition. At the completion of the merger, Dicerna became a wholly-owned subsidiary of Novo Nordisk. The common stock of Dicerna will no longer be listed or traded on the Nasdaq Global Select Market.
• In December 2021, Biocon Ltd partners with Tabuk Pharmaceuticals to commercialize its specialty generic medicines in the Middle East. The partnership will pave the way for Biocon's expansion into the MENA region to include Saudi Arabia, UAE, Kuwait, Qatar, Oman, and Iraq, in addition to Jordan and Lebanon. This is another important milestone for Biocon, reflecting its commitment to providing patients around the globe with affordable medications, by establishing a strong global portfolio of products, either directly, or through strategic partnerships.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET, BY TYPE

• 5.1 Overview
• 5.2 Pharmaceutical Grade
• 5.3 Food Grade
• 5.4 Others

6 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Dietary Supplement
• 6.3 Pharmaceutical Industry
• 6.4 Others

7 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East And Africa

8 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Bontac Bioengineering
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Hubei Widely Chemical Technology
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Allergan
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Synergy Pharmaceuticals
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Novo Nordisk A/S
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Oramed
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Biocon India
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Diabetology
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Catalent
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 EnzymeWorks
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research